Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

The lawyer for a New Kensington man facing a potential death sentence told a Westmoreland County judge Monday a defense-hired ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

Global pharmaceutical company Eli Lilly (NYSE:LLY) in Q4 CY2024, with sales up 44.7% year on year to $13.53 billion. The ...